Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients. — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients. — Stella

Recruiting

Back to End Stage Chronic Renal Failure trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Oman

Jehad Badawi AL LAHAM, Nizwa

Key details

Sponsor

Oman Ministry of Health

Enrollment target

~38 participants

Started

April 2026

Primary completion

September 2026

Age range

13 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov